The fact that the life science industry is a key industry in Denmark is illustrated by numbers, employing more than 49.000 workers and showing impressive export figures - in 2020, the industry accounted for 22 percent of all Danish exports, making it one of the country’s absolutely largest export areas. Furthermore, medical and health science is the highest priority research areas by far, accounting for more than one third of all public research investments. 

Foreign investments also play an important part in the Danish life science industry with foreign investments in life science accounting for almost half of all foreign investments in the Danish industry in 2018. In addition, figures from 2019 shows that 28 percent of the employees in the life science industry are employed in a foreign owned business. 

The new strategy for the Danish life sciences industry is composed of 38 new initiatives in seven main fields. The initiatives in particular aim to improve the conditions for research and development – including clinical trials, the use of health data, secure a highly skilled workforce and deliver on international partnerships and market access for the benefit of patients, healthcare system sustainability and the economy. 

Link to the strategy (in Danish only): Strategy for life science 2021 (sum)